Velphoro is not currently available in the Philippines, and therefore, no pricing information is publicly listed for the country.
Why Isn't Velphoro Available in the Philippines?
The availability of a medication in a specific country often depends on several factors, including regulatory approvals, market demand, and the pharmaceutical company's distribution strategy. Without approval from the Philippine Food and Drug Administration (FDA), Velphoro cannot be legally marketed or sold within the Philippines. Companies typically conduct clinical trials and submit extensive documentation to regulatory bodies in each target market.
What is Velphoro Used For?
Velphoro (sucroferric oxyhydroxide) is a phosphate binder used to control serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis. It works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream. High phosphate levels, a common complication in CKD patients, can lead to serious health issues, including cardiovascular disease.
How Does Velphoro Work?
Velphoro contains sucroferric oxyhydroxide, which dissociates in the gastrointestinal tract to release iron and hydroxide. The ferric iron and oxyhydroxide components bind to dietary phosphate. This binding forms insoluble iron phosphate complexes, which are then excreted from the body. This mechanism effectively reduces the amount of phosphorus absorbed by the patient.
When Did Velphoro Receive FDA Approval?
Velphoro was first approved by the U.S. Food and Drug Administration (FDA) in November 2014 [1]. It has since received approval in other regions, including the European Union [2].
What Are the Side Effects of Velphoro?
Common side effects associated with Velphoro include diarrhea, nausea, vomiting, constipation, and dark stools. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Are There Other Phosphate Binders Available?
Yes, there are several other phosphate binders available for patients with CKD on dialysis. These include calcium-based binders (like calcium acetate and calcium carbonate), non-calcium, non-aluminum binders (like sevelamer carbonate and sevelamer hydrochloride), and lanthanum carbonate. The choice of phosphate binder often depends on individual patient needs, tolerability, and physician recommendation.
Who Manufactures Velphoro?
Velphoro is manufactured by Fresenius Medical Care [3].
Can Velphoro Be Obtained Through Other Countries?
While it may be possible to obtain medications from other countries through personal import, this is generally not recommended due to potential issues with regulation, authenticity, and storage conditions. It is always best to obtain prescription medications through authorized channels and with the guidance of a healthcare professional.
What is the Patent Status of Velphoro?
Information regarding the patent status of Velphoro and potential patent expiries can be found on specialized patent tracking websites. For instance, DrugPatentWatch.com provides data on drug patents [4]. The patent landscape for pharmaceuticals is complex and can involve multiple patents covering different aspects of a drug, such as its composition, manufacturing process, and methods of use.
---
Sources:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/velphoro-sucroferric-oxyhydroxide-information
[2] https://www.ema.europa.eu/en/medicines/human/EPAR/velphoro
[3] https://www.freseniusmedicalcare.com/en/products-and-services/dialysis-products-and-services/medications/velphoro
[4] https://www.drugpatentwatch.com/